Evidence for DNA Damage as a Biological Link Between Diabetes and Cancer
暂无分享,去创建一个
[1] Jie Du,et al. Potential role of Akt signaling in chronic kidney disease. , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[2] D. Adams,et al. Mutation, clonal fitness and field change in epithelial carcinogenesis , 2014, The Journal of pathology.
[3] K. Gundogan,et al. Evaluation of chromosomal damage, cytostasis, cytotoxicity, oxidative DNA damage and their association with body-mass index in obese subjects. , 2014, Mutation research. Genetic toxicology and environmental mutagenesis.
[4] R. Ozaki,et al. Additive effects of blood glucose lowering drugs, statins and renin-angiotensin system blockers on all-site cancer risk in patients with type 2 diabetes , 2014, BMC Medicine.
[5] E. Schleicher,et al. Effect of metformin on methylglyoxal metabolism in patients with type 2 diabetes. , 2014, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[6] S. Liang,et al. Hyperactivation of Akt/mTOR and deficiency in tuberin increased the oxidative DNA damage in kidney cancer patients with diabetes , 2014, Oncotarget.
[7] M. Ng,et al. Genetic variants for type 2 diabetes and new-onset cancer in Chinese with type 2 diabetes. , 2014, Diabetes research and clinical practice.
[8] Carlos Sonnenschein,et al. One hundred years of somatic mutation theory of carcinogenesis: Is it time to switch? , 2014, BioEssays : news and reviews in molecular, cellular and developmental biology.
[9] Joung-Sun Park,et al. Mechanism of metformin: Inhibition of DNA damage and proliferative activity in Drosophila midgut stem cell , 2013, Mechanisms of Ageing and Development.
[10] K. Asanuma,et al. Telmisartan inhibits AGE-induced podocyte damage and detachment. , 2013, Microvascular research.
[11] H. Stopper,et al. Insulin mediated DNA damage in mammalian colon cells and human lymphocytes in vitro. , 2013, Mutation research.
[12] Y. Bao,et al. Cancer Incidence and Mortality in Patients with Type 2 Diabetes Treated with Human Insulin: A Cohort Study in Shanghai , 2013, PloS one.
[13] Cynthia J. Sakofsky,et al. Break-Induced Replication and Genome Stability , 2012, Biomolecules.
[14] Xilin Yang,et al. Diabetes and cancer: the mechanistic implications of epidemiological analyses from the Hong Kong Diabetes Registry , 2012, Diabetes/metabolism research and reviews.
[15] N. R. Jena. DNA damage by reactive species: Mechanisms, mutation and repair , 2012, Journal of Biosciences.
[16] H. G. van der Poel,et al. Akt-mediated phosphorylation of Bmi1 modulates its oncogenic potential, E3 ligase activity, and DNA damage repair activity in mouse prostate cancer. , 2012, The Journal of clinical investigation.
[17] J. Burgess,et al. Differential effects of α-tocopherol and N-acetyl-cysteine on advanced glycation end product-induced oxidative damage and neurite degeneration in SH-SY5Y cells. , 2012, Biochimica et biophysica acta.
[18] G. Bochi,et al. Association between DNA strand breakage and oxidative, inflammatory and endothelial biomarkers in type 2 diabetes. , 2012, Mutation research.
[19] Yuanzhi Lao,et al. Akt: A Double-Edged Sword in Cell Proliferation and Genome Stability , 2012, Journal of oncology.
[20] A. Vikram,et al. Alkaline, Endo III and FPG modified comet assay as biomarkers for the detection of oxidative DNA damage in rats with experimentally induced diabetes. , 2011, Mutation research.
[21] Xin Gao,et al. Diabetes causes multiple genetic alterations and downregulates expression of DNA repair genes in the prostate , 2011, Laboratory Investigation.
[22] Pingsheng Liu,et al. Palmitic acid acutely stimulates glucose uptake via activation of Akt and ERK1/2 in skeletal muscle cells[S] , 2011, Journal of Lipid Research.
[23] H. Jelinek,et al. Oxidative DNA damage and obesity in type 2 diabetes mellitus. , 2011, European journal of endocrinology.
[24] Toru Kagawa,et al. Possible involvement of intracellular angiotensin II receptor in high-glucose-induced damage in renal proximal tubular cells. , 2011, Journal of nephrology.
[25] Mark I McCarthy,et al. Genomics, type 2 diabetes, and obesity. , 2010, The New England journal of medicine.
[26] Edward Giovannucci,et al. Diabetes and Cancer , 2010, Diabetes Care.
[27] M. Goodarzi,et al. Oxidative damage to DNA and lipids: correlation with protein glycation in patients with type 1 diabetes , 2010, Journal of clinical laboratory analysis.
[28] Xilin Yang,et al. Associations of Hyperglycemia and Insulin Usage With the Risk of Cancer in Type 2 Diabetes: The Hong Kong Diabetes Registry , 2010, Diabetes.
[29] James E. Klaunig,et al. Oxidative Stress and Oxidative Damage in Carcinogenesis , 2010, Toxicologic pathology.
[30] S. Habib,et al. Molecular mechanism of regulation of OGG 1 : tuberin deficiency results in cytoplasmic redistribution of transcriptional factor , 2010 .
[31] Weiping Jia,et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. , 2009, JAMA.
[32] H. Abboud,et al. Mechanism of Oxidative DNA Damage in Diabetes , 2008, Diabetes.
[33] J. Błasiak,et al. In vitro effect of gliclazide on DNA damage and repair in patients with type 2 diabetes mellitus (T2DM). , 2008, Chemico-biological interactions.
[34] Xilin Yang,et al. Predicting values of lipids and white blood cell count for all-site cancer in type 2 diabetes. , 2008, Endocrine-related cancer.
[35] X. Adiconis,et al. PPARGC1A Variation Associated With DNA Damage, Diabetes, and Cardiovascular Diseases , 2008, Diabetes.
[36] Xilin Yang,et al. Development and validation of an all-cause mortality risk score in type 2 diabetes. , 2008, Archives of internal medicine.
[37] Ying Zhang,et al. High level glucose increases mutagenesis in human lymphoblastoid cells , 2007, International journal of biological sciences.
[38] Shuo Yang,et al. Activated IGF-1R inhibits hyperglycemia-induced DNA damage and promotes DNA repair by homologous recombination. , 2005, American journal of physiology. Renal physiology.
[39] A. Heidland,et al. Genotoxicity of Advanced Glycation End Products: Involvement of Oxidative Stress and of Angiotensin II Type 1 Receptors , 2005, Annals of the New York Academy of Sciences.
[40] Janusz Blasiak,et al. DNA damage and repair in type 2 diabetes mellitus. , 2004, Mutation research.
[41] Antonio Ceriello,et al. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. , 2003, Diabetes.
[42] J. Chambers,et al. Linoleic acid and antioxidants protect against DNA damage and apoptosis induced by palmitic acid. , 2003, Mutation research.
[43] M. Evans,et al. Oxidative DNA damage: mechanisms, mutation, and disease , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[44] H. İlkova,et al. DNA damage and antioxidant defense in peripheral leukocytes of patients with Type I diabetes mellitus. , 2003, Mutation research.
[45] Donghui Li,et al. Reduced constitutive 8-oxoguanine-DNA glycosylase expression and impaired induction following oxidative DNA damage in the tuberin deficient Eker rat. , 2003, Carcinogenesis.
[46] A. Heidland,et al. Genotoxicity of advanced glycation end products in mammalian cells. , 2003, Cancer letters.
[47] S. Nicosia,et al. Phosphatidylinositol 3-Kinase/Akt Pathway Regulates Tuberous Sclerosis Tumor Suppressor Complex by Phosphorylation of Tuberin* , 2002, The Journal of Biological Chemistry.
[48] J. Drai,et al. Oxidative stress parameters in type I, type II and insulin-treated type 2 diabetes mellitus; insulin treatment efficiency. , 2002, Clinica chimica acta; international journal of clinical chemistry.
[49] A. Peiris,et al. Insulin: a novel factor in carcinogenesis. , 2002, The American journal of the medical sciences.
[50] Y. Yamori,et al. Phytoestrogens attenuate oxidative DNA damage in vascular smooth muscle cells from stroke‐prone spontaneously hypertensive rats , 2000, Journal of hypertension.
[51] D. Livingston,et al. In search of the tumour-suppressor functions of BRCA1 and BRCA2 , 2000, Nature.
[52] W. Zidek,et al. Reactive oxygen species in essential hypertension and non-insulin-dependent diabetes mellitus. , 1999, American journal of hypertension.
[53] Y. Hinokio,et al. Oxidative DNA damage in diabetes mellitus: its association with diabetic complications , 1999, Diabetologia.
[54] U. Eriksson,et al. Hyperglycemia-induced embryonic dysmorphogenesis correlates with genomic DNA mutation frequency in vitro and in vivo. , 1999, Diabetes.
[55] A. Collins,et al. DNA damage in diabetes: correlation with a clinical marker. , 1998, Free radical biology & medicine.
[56] T. Nicotera,et al. Oxidative damage to DNA in diabetes mellitus , 1996, The Lancet.
[57] H. Joenje,et al. Mutational specificity of oxidative DNA damage. , 1993, Mutation research.
[58] L. Berstein,et al. Glucose consumption, newborn weight and nitrosomethylurea transplacental carcinogenesis in rats. , 1984, Cancer letters.
[59] M. Fox. Fundamentals of Oncology , 1979, British Journal of Cancer.
[60] C. Riggs,et al. Effects of glucose on cloning efficiency and mutagenesis of fetal rat cells. , 2002, Teratogenesis, carcinogenesis, and mutagenesis.
[61] Mara,et al. High glucose induces DNA damage in cultured human endothelial cells. , 1986, The Journal of clinical investigation.